Abstract
Alzheimer's disease (AD) is a highly prevalent neurodegenerative condition that presents with cognitive decline. The current understanding of underlying disease mechanisms remains incomplete. Genetically modified mouse models have been instrumental in deciphering pathomechanisms in AD. While these models were typically generated by classical transgenesis and genome editing, the use of adeno-associated viruses (AAVs) to model and investigate AD in mice, as well as to develop novel gene-therapy approaches, is emerging. Here, we reviewed literature that used AAVs to study and model AD and discuss potential gene therapy strategies.
Original language | English |
---|---|
Pages (from-to) | 3649-3665 |
Number of pages | 17 |
Journal | British Journal of Pharmacology |
Volume | 176 |
Issue number | 18 |
Early online date | 28 Feb 2019 |
DOIs | |
Publication status | Published - 1 Sep 2019 |